Fresenius Medical: High Yield, Utilities-Like Stock At Valuation Lows

FMS is a defensive dialysis services provider with stable and recurring demand and regulated pricing. Profitability is recovering as FME25+ cost savings flow through the business. The stock offers attractive shareholder returns through high free cash flow, dividends, and large buybacks. FMS trades at a historically low valuation despite improving margins and a narrowing gap with DaVita.

Fresenius Medical Care ( FMS ) is a leading dialysis services and equipment provider in the U.S. and internationally. Dialysis is a stable, recurring, and cash-generative business. Fresenius provides an essential service, and prices are regulated to a